Exelixis Inc. buy Guggenheim
Start price
22.01.25
/
50%
€32.38
Target price
22.01.26
-
Performance (%)
15.84%
End price
23.01.26
€37.51
Summary
This prediction ended on 23.01.26 with a price of €37.51. The prediction had a final performance of 15.84%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -8.463% | -8.463% | 37.930% |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% |
Comments by Guggenheim for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten